Autosomal recessive congenital ichthyosis 11 is a rare, inherited skin disease. It starts at birth or early infancy. The skin makes too much scale and does not shed normally. Many patients also grow less scalp hair than usual (hypotrichosis) and may have eye surface irritation. The main reason is harmful changes (pathogenic variants) in a gene called ST14, which encodes a skin enzyme named matriptase. When matriptase does not work well, the outer skin layer cannot mature and separate properly, so scales build up and the skin barrier leaks water. This weak barrier also makes the skin red, itchy, and easy to get infected. PMC+3Monarch Initiative+3Orpha.net+3
ARCI11 is a rare inherited skin condition caused by harmful changes (mutations) in the ST14 gene, which encodes the protease matriptase. It follows an autosomal recessive pattern, so a child is affected when both parents silently carry one faulty copy. Babies usually have very dry, thick, scaly skin from birth, and some have sparse or fragile scalp hair (hypotrichosis) and eyelid problems (ectropion). Because matriptase helps the outer skin layer form a healthy barrier, ST14 mutations weaken that barrier—skin loses water, cracks, and builds scales. ARCI11 is part of the broader ARCI group but is specifically linked to ST14; many reports describe “ichthyosis with hypotrichosis” as the core picture. Diagnosis is clinical plus genetic testing. Treatment focuses on daily skincare, eye protection, and careful use of keratolytics and retinoids; there is no cure yet. Monarch Initiative+3search.thegencc.org+3MalaCards+3
Other names
-
Ichthyosis-hypotrichosis syndrome (IHS)
-
Autosomal recessive ichthyosis with hypotrichosis
-
Autosomal recessive congenital ichthyosis type 11 (ARCI11)
-
ARIH (ichthyosis, hypotrichosis) syndrome
These names all refer to the same condition, usually linked to ST14 variants. Monarch Initiative+1
Types
ARCI11 sits inside the broad ARCI family. ARCI can show two classic skin patterns, and ARCI11 often overlaps with them:
-
Lamellar ichthyosis (LI) – large, plate-like dark scales with little redness. MalaCards
-
Non-bullous congenital ichthyosiform erythroderma (NCIE) – fine white scales on red skin, often with eyelid turning-out (ectropion) and palm/sole thickening. NCBI+1
ARCI11 is special because reduced hair growth (hypotrichosis) is common, and eye surface problems (photophobia, corneal clouding, blepharitis) may appear in some patients. alliancegenome.org
Note: Harlequin ichthyosis is another ARCI form but is usually caused by ABCA12, not ST14. BioMed Central
Causes
All causes below describe why ARCI11 happens or looks worse. The root cause is biallelic (both-copy) pathogenic variants in ST14; the rest are mechanisms or modifiers that shape severity.
-
ST14 loss-of-function variants (nonsense, frameshift, splice) remove or shorten matriptase, so corneocytes fail to separate and scales build up. CAGS
-
ST14 missense variants change key amino acids, altering enzyme activity and stability; the barrier stays leaky. Orpha.net
-
Defective matriptase–prostasin cascade – matriptase helps activate other surface proteases; if this chain fails, normal shedding (desquamation) stalls. PMC
-
Abnormal corneodesmosome processing – “rivets” that hold dead skin cells together do not get cut at the right time, so scales stick. PMC
-
Lipid-barrier disturbance – ARCI as a group shows altered stratum corneum lipids; ST14 dysfunction contributes to barrier lipid disorganization. NCBI
-
Water-loss (TEWL) increase – a leaky barrier lets water out, causing dryness, tightness, and scale; electronic TEWL measures often rise in ARCI. NCBI
-
Secondary inflammation – a broken barrier lets irritants/microbes in, fueling redness, itch, and infections. NCBI
-
Hair-follicle involvement – matriptase is expressed in the hair shaft and matrix; dysfunction leads to hypotrichosis and sometimes scarring alopecia. CAGS
-
Eye surface involvement – chronic lid margin and surface irritation (blepharitis, photophobia) follow from lid/skin changes and dryness. alliancegenome.org
-
Palmoplantar keratoderma – thick palms/soles develop due to hyperkeratosis and microfissures from barrier stress. MalaCards
-
Founder effects/consanguinity – rare variants become more common in some families or regions, increasing ARCI risk when parents are related. ScienceDirect
-
Modifier genes – other ichthyosis-related pathways (lipid enzymes, cornification genes) can modify severity in ARCI. PMC
-
Environmental dryness/cold – low humidity worsens scaling by boosting evaporation and stiffness of the stratum corneum. NCBI
-
Heat and sweating problems – thick scale blocks sweat ducts, causing overheating and prickly heat. NCBI
-
Recurrent skin infection – fissures and micro-tears allow bacteria/yeast in, aggravating redness and odor. NCBI
-
Mechanical friction – rubbing increases local thickening and scales. NCBI
-
Irritant skincare products – harsh soaps and solvents strip lipids and worsen the barrier. NCBI
-
Nutritional stress/low essential lipids – while not causal, poor skin nutrition can worsen dryness and scaling. NCBI
-
Delayed shedding at birth – many ARCI infants (various subtypes) are born in a collodion membrane; desquamation is abnormal from day one. NCBI
-
General ARCI heterogeneity – because ARCI pathways converge on barrier formation, ST14 defects can present across LI–NCIE spectra. MalaCards
Symptoms
-
Generalized scaling – skin over most of the body shows dry, adherent scales of variable size and color. MalaCards
-
Dryness and tightness – skin feels tight after bathing and can crack because the barrier leaks water. NCBI
-
Redness (erythema) – common in NCIE-like presentations and flares with irritation or infection. MalaCards
-
Hypotrichosis – reduced scalp hair density/length; eyebrows and lashes may also be sparse. Orpha.net
-
Alopecia/scarring – some people develop permanent hair loss from chronic inflammation and scale at follicles. MalaCards
-
Itching and discomfort – dryness plus fissures triggers itch and soreness, especially in flexures. NCBI
-
Palmoplantar thickening – thick, painful palms and soles with fissures that split when walking. MalaCards
-
Overheating – blocked sweating and thick scales reduce heat loss during warm weather or exercise. NCBI
-
Recurrent skin infections – cracks and macerated folds invite bacterial/yeast infections. NCBI
-
Eyelid problems (blepharitis) – inflamed lid margins with crusting or irritation. alliancegenome.org
-
Photophobia – light sensitivity due to eye-surface irritation; some patients also report tearing. alliancegenome.org
-
Corneal opacity or pinguecula – long-standing surface irritation may cloud the cornea or form yellowish conjunctival bumps. alliancegenome.org
-
Nail changes – ridging or thickening may appear, especially in NCIE-like phenotypes. MalaCards
-
Collodion membrane at birth – not universal in ARCI11 but recognized across ARCI; tight shiny membrane that later peels. NCBI
-
Psychosocial impact – visible scaling and hair loss can cause embarrassment, anxiety, and social stress. (General ARCI literature). NCBI
Diagnostic tests
A) Physical examination
-
Full-body skin exam – the clinician maps scale size, color, and distribution; notes redness, fissures, odor, and secondary infection to grade severity and plan care. NCBI
-
Hair and scalp assessment – inspection documents hypotrichosis, alopecia patches, and follicular plugging; this supports ARCI11 when paired with ichthyosis. Orpha.net
-
Palm/sole evaluation – looking for keratoderma and painful cracks guides emollient, keratolytic, and footwear advice. MalaCards
-
Eye surface check – lids, conjunctiva, and cornea are examined for blepharitis, photophobia, or clouding; early treatment prevents scarring. alliancegenome.org
-
Infection screen – swabs from fissures or macerated folds may be taken when pus, odor, or rapid redness appears. (General ARCI practice). NCBI
B) “Manual/bedside” tests
-
Desquamation assessment – gentle tape-stripping or scale scraping at bedside shows retained scales and guides strength of keratolytics. (General ARCI approach). NCBI
-
Pruritus scoring and pain scales – simple 0–10 scales track itch and fissure pain and help adjust therapy over time. NCBI
-
Hair pull test/trichoscopy at bedside – quick check of hair fragility and density; trichoscopy can show shaft abnormalities in hypotrichosis. CAGS
-
Hydration/roughness feel test – clinicians palpate skin to judge dryness and rigidity; this is crude but useful in routine visits. NCBI
-
Ocular surface staining (fluorescein) – simple dye test at the slit lamp highlights dry spots and erosions on the cornea. alliancegenome.org
C) Laboratory & pathological tests
-
Genetic testing (ARCI panel or exome) – confirms biallelic ST14 variants and distinguishes ARCI11 from other ARCI genes (TGM1, NIPAL4, ALOX12B, ALOXE3, CERS3, PNPLA1, CYP4F22, ABCA12, etc.). Genetic proof directs counseling and future trials. NCBI+1
-
Targeted ST14 sequencing – when family history suggests ARCI11, direct sequencing of ST14 can be faster and cheaper. CAGS
-
Skin biopsy (optional) – shows marked hyperkeratosis and acanthosis; findings support a keratinization disorder but are not fully specific in ARCI. MalaCards
-
Microbiology (bacterial/fungal) – culture helps guide antibiotics or antifungals for secondary infection. NCBI
-
Basic labs – usually normal; ordered to rule out mimics or complications (e.g., high inflammatory markers during superinfection). NCBI
-
Lipid/barrier research assays – specialized centers may analyze stratum-corneum lipids to study barrier defects in ARCI. NCBI
D) Electrodiagnostic/device-based tests
-
Transepidermal water loss (TEWL) measurement – an electronic probe measures water escaping from skin; numbers are typically elevated in ARCI and track barrier repair. NCBI
-
Cutaneous impedance/corneometry – electronic meters estimate hydration or barrier function; useful for monitoring emollient response. NCBI
E) Imaging & specialized optics
-
Dermoscopy/trichoscopy imaging – handheld optics magnify scales, fissures, and hair shafts; documents hypotrichosis patterns in ARCI11. CAGS
-
Ocular imaging – slit-lamp photos, anterior segment OCT, or corneal topography document corneal opacity or surface irregularity in patients with photophobia. alliancegenome.org
Non-pharmacological treatments (therapies & others)
1) Thick emollient routine (petrolatum/occlusive bases). Apply several times daily, especially after bathing, to trap water and soften scales; occlusives are the backbone of ARCI care across guidelines. akademiska.se+2FDA Access Data+2
2) Short, lukewarm baths with soak-and-seal. Brief soaks loosen scale; pat dry and seal immediately with ointment to reduce transepidermal water loss. akademiska.se
3) Humidification and climate control. Indoor humidifiers and avoiding overheated, dry air reduce cracking and pruritus; this is standard supportive care. akademiska.se
4) Gentle mechanical descaling. After soaking, cautiously use a soft cloth or flexible sponge to lift loosened scale (avoid aggressive scraping to prevent fissures). akademiska.se
5) Eye surface protection. Frequent preservative-free lubricating drops/ointment protect the cornea in ectropion or incomplete lid closure; urgent ophthalmology if irritation, redness, or pain. EyeWiki+2ichthyosis.org.uk+2
6) Eyelid emollient and massage programs. Regular lid skin softening and gentle massage can reduce retraction and improve blink closure in some patients. ichthyosis.org.uk
7) Neonatal intensive skin care. In collodion/very thick scale at birth, coordinated nursing, temperature control, humidified incubator, and ocular lubrication are recommended.
8) Sun and wind protection. Broad-brim hats and physical sunscreens lower irritation and water loss from compromised barrier skin. akademiska.se
9) Ear-canal hygiene. Regular softening and careful removal of keratin plugs by clinicians prevents conductive hearing loss and infections; avoid cotton swabs. PubMed+2firstskinfoundation.org+2
10) Nail and palm/sole care. Soaks plus emollients limit painful fissures; podiatry input helps with hyperkeratotic soles and gait comfort. akademiska.se
11) Itch management without drugs. Cool compresses, moisturizers, and trigger avoidance (fragrance, wool) reduce scratching and secondary infection risk. akademiska.se
12) Psychosocial support and education. Teaching families daily routines and connecting with patient groups improves adherence and quality of life. ern-skin.eu
13) Infection prevention hygiene. Gentle cleansing of fissures and early medical review for redness, warmth, or oozing helps prevent cellulitis. akademiska.se
14) Protective dressings for fissures. Hydrogel or petrolatum gauze dressings cushion cracks on hands/feet during flares. akademiska.se
15) Scalp scale care. Emollient soaks and gentle brushing after softening reduce adherent scale without traumatizing sparse hair. akademiska.se
16) Temperature regulation. Light, breathable clothing layers help patients with limited sweating tolerate heat and exercise. akademiska.se
17) Dental and oral comfort. Lip emollients and avoidance of irritating foods reduce fissuring at mouth corners in severe dryness. akademiska.se
18) Regular ophthalmology follow-up. Scheduled eye checks detect early corneal exposure and scarring, especially when ectropion is present. EyeWiki
19) ENT follow-up for chronic ear scale. Periodic aural toileting prevents keratosis obturans and hearing decline. PubMed
20) Surgical consult when needed. If ectropion threatens the cornea or causes persistent exposure, combined medical–surgical management with grafting can preserve vision. PMC+1
Drug treatments
Important: No drug is FDA-approved specifically for ARCI11. The agents below are widely used to soften scale, normalize keratinization, or protect skin/eyes; their FDA labels are for other indications, but they describe mechanism, dosing ranges, and safety used to guide off-label care in ichthyoses. Always individualize with a dermatologist.
1) Acitretin (oral retinoid). Retinoid that normalizes epidermal differentiation; used off-label for severe keratinization disorders to reduce scale thickness. Typical psoriasis dosing 10–50 mg daily; teratogenic with prolonged contraception requirements; monitor lipids and liver. FDA Access Data
2) Isotretinoin (oral retinoid). Alters keratinization and reduces hyperkeratosis; sometimes preferred in adolescents. Strict teratogenicity precautions (iPLEDGE), mucocutaneous dryness, lab monitoring. FDA Access Data+1
3) Tazarotene (topical retinoid 0.05–0.1%). Retinoid prodrug that binds RARs, used off-label in localized thick plaques; avoid during pregnancy and on eczematous skin due to irritation. FDA Access Data+1
4) Urea 20–40% (topical keratolytic/emollient). Breaks hydrogen bonds in keratin, hydrates, and softens scales; applied nightly with occlusion for thick areas. Local irritation possible. DailyMed+1
5) Ammonium lactate 12% (topical humectant/keratolytic). Lactic-acid salt improves hydration and gentle desquamation; apply once–twice daily; stinging on fissured skin. FDA Access Data+1
6) Salicylic acid 3–6% (topical keratolytic). Helps remove thick scale on palms/soles/scalp; avoid large surface areas in young children to reduce systemic absorption. DailyMed+1
7) White petrolatum 100% (skin protectant). FDA OTC monograph skin-protectant; seals moisture, reduces friction, and protects minor cuts/fissures. FDA Access Data+1
8) Mineral-oil/glycerin emollients. Monograph-based skin protectants/humectants used as daily bases to reduce transepidermal water loss and itch. FDA Access Data
9) Ophthalmic petrolatum lubricants. Night-time ointments reduce corneal exposure in ectropion; frequent daytime artificial tears as needed. jaapos.org
10) Topical antibiotics (erythromycin, mupirocin) for secondary impetiginization. Short courses only when infection is present per clinician. akademiska.se
11) Oral antibiotics for cellulitis. When fissures become infected, systemic therapy per culture/local guidelines is used. akademiska.se
12) Low-potency topical corticosteroids for dermatitis around scales. Short bursts for eczematous edges to calm itch and allow emollient tolerance; avoid chronic daily use on thin skin. akademiska.se
13) Coal tar shampoos for scalp hyperkeratosis. Keratoplastic effect; used intermittently when tolerated. akademiska.se
14) Keratolytic shampoo with salicylic acid 3–6%. Aids scale lift on scalp with gentle comb-out after softening. DailyMed
15) Urea-based foot creams with occlusion. Night occlusion enhances penetration over thick plantar keratoderma; caution if fissured. DailyMed
16) Lactic acid lotions (10–12%) for widespread dryness. Alternate with petrolatum to balance hydration and irritation risk. FDA Access Data
17) Combination regimens (e.g., urea + retinoid). Sequential keratolytic then retinoid can improve thick plaques more than either alone; monitor irritation closely. akademiska.se
18) Ophthalmic antibiotic ointment (e.g., erythromycin) during lid inflammation. Used with heavy lubrication to protect compromised corneas. jaapos.org
19) Barrier-repair creams containing ceramides (non-Rx). Guideline-endorsed as part of emollient base to reinforce lipid barrier; use after bathing. akademiska.se
20) Pain control for fissures (topical anesthetic sparing use). Short, clinician-directed use only on small areas to enable care; avoid routine use. akademiska.se
Dietary molecular supplements
Important: No supplement cures ARCI11. Use as adjuncts only, and discuss with clinicians—especially with retinoids.
1) Omega-3 fatty acids (fish oil). Anti-inflammatory lipid support may modestly help dryness/itch in some keratinization disorders; evidence is limited but biologically plausible. akademiska.se
2) Vitamin D (within safe limits). Deficiency is common in chronic skin disease; correcting deficiency may help overall skin health and immunity. akademiska.se
3) Biotin (only if deficient). Routine biotin is not proven in ARCI but deficiency can worsen hair/skin brittleness; confirm status first. akademiska.se
4) Zinc (only if low). Zinc deficiency causes dermatitis; repletion helps barrier enzymes; avoid excess. akademiska.se
5) Evening primrose/GLA. May support epidermal lipids in some xerotic conditions; benefit uncertain. akademiska.se
6) Probiotics (general skin support). Mixed evidence for eczema-type dryness; not disease-specific for ARCI. akademiska.se
7) Collagen peptides. Can improve skin hydration/elasticity in small studies; no ARCI-specific trials. akademiska.se
8) Antioxidant mix (vitamin C/E) within RDA. Supports wound healing around fissures; avoid mega-doses. akademiska.se
9) Niacinamide (oral or topical). Supports barrier lipids and reduces TEWL; used widely in xerosis products. akademiska.se
10) L-carnitine (experimental rationale). Mitochondrial lipid handling support has theoretical benefit only; not standard of care. akademiska.se
Immunity-booster / regenerative / stem-cell drugs
At this time there are no FDA-approved immune-boosting, regenerative, or stem-cell drugs for ARCI11 or ichthyosis. Care relies on emollients, keratolytics, cautious use of retinoids, infection control, and surgery when needed. Research into barrier-lipid pathways (e.g., retinoid/vitamin-A metabolism in ARCI subtypes) and gene-targeted therapy is ongoing but not yet approved. PubMed
Surgeries (procedures & why)
1) Ectropion repair with skin grafts. When persistent eyelid eversion exposes the cornea, full-thickness skin grafting (retroauricular/supraclavicular) with lubrication protects vision. PMC+1
2) Combined medical–surgical ectropion approach. Pre-op topical softening then release and grafting improves graft take and eyelid position. PMC
3) Urgent ectropion release in threatened cornea. Early release prevents ulceration and scarring in severe neonatal/infant ectropion. JAAD+1
4) Aural keratin plug removal (clinic/minor OR). When heavy ear canal keratin causes blockage or infection, formal aural toileting under microscopy is performed. PubMed
5) Contracture/fissure debridement and closure (selected cases). Painful, non-healing fissures or contractures may need limited surgical care for function and pain relief. akademiska.se
Preventions
-
Daily thick emollients after every bath. akademiska.se
-
Avoid fragranced/harsh cleansers and hot water. akademiska.se
-
Use humidifiers in dry seasons/rooms. akademiska.se
-
Protective gloves/socks for friction-prone areas. akademiska.se
-
Prompt care of small cuts to prevent cellulitis. akademiska.se
-
Regular eye lubrication in ectropion; urgent review for pain/redness. EyeWiki
-
Scheduled ENT/ophthalmology/dermatology follow-ups. PubMed
-
Heat-safety planning (cool environment, fluids). akademiska.se
-
Education for caregivers about soak-and-seal routines. ern-skin.eu
-
Genetic counseling for family planning.
When to see doctors
See a dermatologist for uncontrolled scale, fissures, or suspected infection; see ophthalmology urgently for eye pain, light sensitivity, redness, or vision change; see ENT for hearing loss or blocked ears. Families planning pregnancy should seek genetic counseling and carrier testing. akademiska.se+2EyeWiki+2
What to eat & what to avoid
Eat: balanced diet with adequate protein, essential fatty acids (e.g., fish), vitamin D and zinc within recommended intakes to support skin repair; hydrate well, especially in hot weather. Avoid/limit: very spicy, acidic, or salty foods if lip fissures are painful; avoid supplements in mega-doses without clinician advice, especially when using retinoids. akademiska.se
FAQs
1) Is ARCI11 the same as all ARCI? No—ARCI11 is the ST14-related subtype; ARCI includes many genes with overlapping skin signs. search.thegencc.org
2) How is ARCI11 confirmed? By genetic testing showing biallelic ST14 variants in someone with typical features. search.thegencc.org
3) Is there a cure? Not yet; treatment is lifelong barrier care, keratolytics, and eye/ear protection. akademiska.se
4) Do retinoids help? Yes, in carefully selected cases they reduce scale; they are off-label and require strict safety monitoring. FDA Access Data+1
5) Are retinoids safe in pregnancy? No—oral and many topical retinoids are teratogenic; strict contraception is required. FDA Access Data+2FDA Access Data+2
6) Can infants use keratolytics? Limited, targeted use under specialist guidance; avoid high-strength salicylic acid on large areas. DailyMed
7) What about ceramide creams? Helpful as part of daily emollient routines to reinforce barrier lipids. akademiska.se
8) Do supplements cure ARCI11? No; they are adjuncts at best. Correct deficiencies rather than mega-dosing. akademiska.se
9) Why are eyes at risk? Ectropion exposes the cornea, causing dryness, infection, and scarring; lubrication and sometimes surgery protect vision. EyeWiki+1
10) Why are ears at risk? Keratin debris can block the canal and reduce hearing; periodic professional cleaning is important. PubMed
11) Are stem-cell or gene therapies available? Not yet for ARCI11 in clinical practice. Research is ongoing.
12) What is the long-term outlook? With consistent care and specialist follow-up, many patients achieve good comfort and function, though daily routines are lifelong. akademiska.se
13) Can ARCI11 affect sweating/temperature? Yes; some patients have reduced sweating—plan for heat and exercise carefully. akademiska.se
14) Should families get genetic counseling? Yes—helps interpret carrier status, recurrence risk, and prenatal options.
15) What support exists? Patient groups and guideline resources provide practical day-to-day advice and community. ern-skin.eu
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: October 06, 2025.
